Streetbeat News

Products Services

AEMD

Aethlon Medical has received ethics committee approval to conduct a Hemopurifier cancer trial in India. The trial targets patients with solid tumors unresponsive to anti-PD-1 therapy.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 12:04 pm

CRMD

CorMedix Inc. has signed a new commercial agreement to supply DefenCath to over 250 outpatient dialysis clinics in the US, expanding its market reach. The product, approved under the LPAD pathway, is set to begin shipments in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 12:04 pm

AIM

AIM ImmunoTech has announced preliminary data from its Phase 1b/2 study of Ampligen in combination with Imfinzi. The study shows stable disease in two out of three patients at 6 months in the first subject cohort.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 12:04 pm

AMZN

NTAP

NetApp has entered into a strategic collaboration with Amazon Web Services (AWS) to enhance cloud-based data services, accelerate generative AI efforts, and drive CloudOps value. This partnership aims to leverage AWS's cloud infrastructure to improve NetApp's offerings.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 12:04 pm

EVAX

Evaxion has updated its EDEN AI prediction model to include a novel toxin antigen predictor, potentially enhancing its capabilities in vaccine development.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 12:03 pm

LFMD

LifeMD, Inc. (NASDAQ:LFMD) has announced enhancements to its weight management program, including improved access to GLP-1 therapies, a new platform for in-home lab collection, and technology upgrades for pharmacy benefits. These changes aim to reduce barriers to medication access and improve patient care.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 12:02 pm

HUMA

Humacyte has announced the U.S. patent allowance for its BioVascular Pancreas (BVP), which could be a potential treatment for Type 1 Diabetes. This development may enhance Humacyte's position in the biotechnology sector.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 12:02 pm

WKSP

Worksport Ltd. has initiated the alpha launch of its SOLIS solar array and COR mobile battery power generator, a nano-grid system offering portable power solutions. The system is designed for various applications, including vehicles and outdoor activities, and is set to undergo testing before a full market launch.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 12:02 pm

MCHP

Microchip Technology (NASDAQ:MCHP) has launched the Microchip Graphics Suite (MGS), a solution to simplify the development of graphical user interfaces (GUIs) for embedded systems. MGS integrates with Microchip's 32-bit microcontrollers and microprocessors, supporting platforms like MPLAB Harmony v3 and Linux. It offers tools for hardware-free prototyping and supports a wide range of display types, enhancing design efficiency and reducing errors.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 11:57 am

COHR

Coherent shares rose following the launch of an energy-efficient dual-chip 980 nm micro-pump laser, indicating positive market reception.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 11:57 am